Corcept Beats Teva Bid to Invalidate Korlym Patent on Appeal – Bloomberg Law

Teva Pharmaceuticals USA Inc. failed to convince the Federal Circuit that the patent office should have invalidated Corcept Therapeutics Inc.’s …